← SynDRA
LIRIMILAST
SynDRA canonical compound SYN0028416 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Mechanism of action | phosphodiesterase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- phosphodiesterase inhibitor
- PDE4B INHIBITOR
- PDE4D INHIBITOR
- PDE4A INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- Methanesulfonic acid 2-(2,4-dichlorophenylcarbonyl)-3-ureidobenzofuran-6-ylester
- Lirimilast [INN]
- GDK3KY5FCU
- UNII-GDK3KY5FCU
- LIRIMILAST [WHO-DD]
- LIRIMILASTUM
- RefChem:153648
- DTXCID10109073
- BAY 19-8004
- SMR004703312
- MLS006011546
- MLS006011981
- C17H12Cl2N2O6S
- SCHEMBL450016
- orb1707063
- EX-A5382
- MFCD09837901
- AKOS040741961
- BAY19-8004
- NCGC00263118-01
- HY-19672
- MS-27976
- CS-0016186
- NS00126999
- E98791
- EN300-139811
- T15766
- SR-01000945274
- SR-01000945274-1
- BRD-K31339321-001-01-0
- BRD-K31339321-001-03-6
Look up LIRIMILAST in the interactive SynDRA portal →